APA (7th ed.) Citation

HM, J., WAE, P., & RF, S. (2026). Single-Site Experience in the ONSET-OFFSET Study Demonstrates Pharmacodynamic and Pharmacokinetic Advantages of Ticagrelor over Clopidogrel in Patients with Chronic Coronary Syndromes. Journal of cardiovascular development and disease, 13(3), . https://doi.org/10.3390/jcdd13030144

Chicago Style (17th ed.) Citation

HM, Judge, Parker WAE, and Storey RF. "Single-Site Experience in the ONSET-OFFSET Study Demonstrates Pharmacodynamic and Pharmacokinetic Advantages of Ticagrelor over Clopidogrel in Patients with Chronic Coronary Syndromes." Journal of Cardiovascular Development and Disease 13, no. 3 (2026). https://doi.org/10.3390/jcdd13030144.

MLA (9th ed.) Citation

HM, Judge, et al. "Single-Site Experience in the ONSET-OFFSET Study Demonstrates Pharmacodynamic and Pharmacokinetic Advantages of Ticagrelor over Clopidogrel in Patients with Chronic Coronary Syndromes." Journal of Cardiovascular Development and Disease, vol. 13, no. 3, 2026, https://doi.org/10.3390/jcdd13030144.